CUDC-101 / Curis  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CUDC-101 / Curis
NCT00728793: A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of CUDC-101 in Patients With Advanced Solid Tumors

Checkmark In pts with adv solid tumors
Aug 2014 - Aug 2014: In pts with adv solid tumors
Completed
1
25
US
CUDC-101
Curis, Inc.
Tumors
04/10
04/10
NCT01171924: A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors

Checkmark P1b expansion trial data at 2012 EORTC meeting
Nov 2012 - Nov 2012: P1b expansion trial data at 2012 EORTC meeting
Checkmark P1 data
Nov 2012 - Nov 2012: P1 data
Completed
1
47
US
CUDC-101
Curis, Inc.
Head and Neck Cancer, Liver Cancer, Breast Cancer, Gastric Cancer, Non-Small Cell Lung Cancer
10/11
10/11
NCT01702285: Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Orally Administered CUDC-101 in Cancer Patients

Terminated
1
3
US
CUDC-101
Curis, Inc.
Cancer
12/12
12/12
NCT01384799: Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer

Checkmark AACR-NCI-EORTC 2013
Oct 2013 - Oct 2013: AACR-NCI-EORTC 2013
Completed
1
12
US
CUDC-101, Cisplatin, cisplatinum, CDDP, Platinol, Radiation Therapy
Curis, Inc.
Head and Neck Cancer
09/13
10/13

Download Options